CIK 0000906709
- Non-accelerated filer
- Smaller reporting company
NEKTAR THERAPEUTICS
Sign in to watch- Ticker
- NKTR
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 943134940
- Phone
- +1 415-482-5300
- Business address
- 455 MISSION BAY BOULEVARD SOUTH, SAN FRANCISCO, CA, 94158
- Former names
- INHALE THERAPEUTIC SYSTEMS INC, INHALE THERAPEUTIC SYSTEMS
- 4 Open-market sale Director sold 6,750 shares at $56.76 ($383,130)
- 4 Open-market sale Director sold 10,000 shares at $67.39 ($673,900)
- 4 Open-market sale Director sold 30,000 shares at an average $59.96 ($1,798,800)
- 4 Returned to the company SVP & Chief Accounting Officer returned 4,883 shares (to the company)
- 4 Returned to the company SVP & Chief Operating Officer returned 8,137 shares (to the company)
- 4 Returned to the company SVP & Chief Financial Officer returned 8,207 shares (to the company)
- 4 Returned to the company SVP Pharma Dev & Mfg Ops returned 5,946 shares (to the company)
- 4 Returned to the company President & CEO returned 60,389 shares (to the company)
- 4 Returned to the company SVP & Chief Scientific Officer returned 6,701 shares (to the company)
- 4 Open-market sale Director sold 34,250 shares at an average $60.60 ($2,075,379)
- 4 Open-market sale President & CEO sold 130,000 shares at an average $49.52 ($6,438,036)
- 4 Open-market buy Director bought 5,000 shares at an average $58.04 ($290,212)
- 4 Open-market sale Director sold 10,000 shares at $55.16 ($551,600)
- 4 Open-market sale Director sold 10,000 shares at an average $60.28 ($602,786)
- 4 Open-market sale SVP & Chief Accounting Officer sold 3,576 shares at $83.39 ($298,203)
- 4 Open-market sale President & CEO sold 12,791 shares at $83.39 ($1,066,641)
- 4 Open-market sale SVP & Chief Operating Officer sold 4,917 shares at $83.39 ($410,029)
- 4 Open-market sale SVP & Chief Financial Officer sold 4,941 shares at $83.39 ($412,030)
- 4 Open-market sale SVP Pharma Dev & Mfg Ops sold 4,060 shares at $83.39 ($338,563)
- 4 Open-market sale SVP & Chief Scientific Officer sold 3,435 shares at $83.39 ($286,445)
Page 17 of 49 · 970 filings